• No results found

Influence of SLCO1B1 and CYP2C8gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers

N/A
N/A
Protected

Academic year: 2020

Share "Influence of SLCO1B1 and CYP2C8gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. PCR primers, pyrosequencing primers and PCR annealing temperatures used for genotyping
Figure 1. Rosiglitazone plasma concentration–time curves bySLCO1B1 diplotype group. Closed circles represent SLCO1B1diplotype Group 1 (subjects with the *1A/*1A diplotype)
Table 3. Rosiglitazone pharmacokinetic parameters by SLCO1B1 diplotype group

References

Related documents

MedAustron facility at beam height. A full annual ambient dose equivalent map of the MedAustron accelerator facility as well as close surroundings can be obtained by summation of the

Global health care policy, as previously mentioned, now has a strong self-care focus and various strategies have been put in place to encourage consumers (and pharmacists) to have

Services have well-defined interfaces based standard protocols (usually web-services but most definitions mention that it is not the only possible implementation) as well

Neoclassical economists justify applying reproduction cost because it most accurately represents the workings of a competitive economy. In the long ran, a competitive economy

T he most informative studies of the effects of environmental chemicals on the endocrine sys- tem in children concern 2 ubiquitous, persis- tent halogenated organic pollutant

She also had Kapha– vata prakriti, avar sara (sub optimal body tissue), madhyam samhanan (optimal body built), madhyam satmya (optimal homologa- tion), and avar satva

The models, calibrated in a case study on the Noce river in the Basilicata region (Italy), were applied at the basin scale, allowing one to as- sess preliminary and final hazard maps

Therefore, although immunofluorescence detected a significant increase in cell surface SR-BLII expression in macrophages upon cholesterol loading, it remains